<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00885638</url>
  </required_header>
  <id_info>
    <org_study_id>Lund University Diabetes 001</org_study_id>
    <nct_id>NCT00885638</nct_id>
  </id_info>
  <brief_title>Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion</brief_title>
  <official_title>Study of the Effect of Sitagliptin on the Hormonal Responses to Macronutrient Ingestion in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lund University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The regulation by DPP-4 inhibition after ingested of different individual macronutrients is
      not known. Therefore, this study examines the influence of ingestion of fat, protein, glucose
      or mixed meal on the concentrations of incretin hormones and insulin secretion with or
      without concomitant administration of a DPP-4 inhibitor (sitagliptin).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Meal ingestion releases gut hormones which stimulate insulin secretion. A most important gut
      hormone is the incretin hormone glucagon-like peptide-1 (GLP-1). GLP-1 is rapidly degraded
      and inactivated after its release by the enzyme dipeptidyl peptidase-4 (DPP-4). Inhibition of
      DPP-4 therefore increases the concentration of active GLP-1 after meal ingestion, which
      augments insulin secretion. How this process is regulated after ingested of different
      individual macronutrients is not known. Therefore, this study examines the influence of
      ingestion of fat, protein, glucose or mixed meal on the concentrations of incretin hormones
      and insulin secretion with or without concomitant administration of a DPP-4 inhibitor
      (sitagliptin).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucagon-like Peptide-1 Secretion After Meal Ingestion</measure>
    <time_frame>300 min</time_frame>
    <description>Plasma GLP-1 levels will be measured during 300 min after meal ingestion for estimation of GLP-1 secretion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin Secretion After Ingestion of Meal</measure>
    <time_frame>300 min</time_frame>
    <description>Plasma insulin levels will be measured during 300 min after meal ingestion to estimation of insulin secretion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A placebo tablet is given before ingestion of macronutrients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sitagliptin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sitagliptin is given before ingestion of macronutrients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sitagliptin</intervention_name>
    <description>100 mg sitagliptin before ingestion of macronutrient</description>
    <arm_group_label>Sitagliptin</arm_group_label>
    <other_name>Januvia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>A placebo tablet is given before ingestion of macronutrients</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men

          -  Age 20-30 years

          -  BMI 20-30 kg/m2

        Exclusion Criteria:

          -  Any disease

          -  Any medication
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bo Ahrén, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Clinical Sciences Lund, Lund University</name>
      <address>
        <city>Lund</city>
        <zip>221 84</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Carr RD, Larsen MO, Winzell MS, Jelic K, Lindgren O, Deacon CF, Ahrén B. Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E779-84. doi: 10.1152/ajpendo.90233.2008. Epub 2008 Jul 8.</citation>
    <PMID>18612044</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2009</study_first_submitted>
  <study_first_submitted_qc>April 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2009</study_first_posted>
  <results_first_submitted>September 21, 2012</results_first_submitted>
  <results_first_submitted_qc>December 7, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 15, 2013</results_first_posted>
  <last_update_submitted>December 25, 2013</last_update_submitted>
  <last_update_submitted_qc>December 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lund University</investigator_affiliation>
    <investigator_full_name>Bo Ahren</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>GLP-1</keyword>
  <keyword>Insulin secretion</keyword>
  <keyword>Macronutrients</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sitagliptin Phosphate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment was performed during 2011 to Lund University</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo First, Then Sitagliptin</title>
          <description>First intervention 1 day, washout 14 days, second intervention 1 day</description>
        </group>
        <group group_id="P2">
          <title>Sitagliptin First, Then Placebo</title>
          <description>First intervention 1 day, washout 14 days, second intervention 1 day</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Placebo first, then sitagliptin or sitagliptin first, then placebo</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.5" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Glucagon-like Peptide-1 Secretion After Meal Ingestion</title>
        <description>Plasma GLP-1 levels will be measured during 300 min after meal ingestion for estimation of GLP-1 secretion</description>
        <time_frame>300 min</time_frame>
        <population>Completer population</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo first, then sitagliptin or sitagliptin first, then placebo; this is the result for placebo</description>
          </group>
          <group group_id="O2">
            <title>Sitagliptin</title>
            <description>Placebo first, then sitagliptin or sitagliptin first, then placebo; this is the result for sitagliptin</description>
          </group>
        </group_list>
        <measure>
          <title>Glucagon-like Peptide-1 Secretion After Meal Ingestion</title>
          <description>Plasma GLP-1 levels will be measured during 300 min after meal ingestion for estimation of GLP-1 secretion</description>
          <population>Completer population</population>
          <units>nmol/l/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" spread="0.11"/>
                    <measurement group_id="O2" value="1.24" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Insulin Secretion After Ingestion of Meal</title>
        <description>Plasma insulin levels will be measured during 300 min after meal ingestion to estimation of insulin secretion</description>
        <time_frame>300 min</time_frame>
        <population>Completer population</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>A placebo tablet is given before ingestion of meal</description>
          </group>
          <group group_id="O2">
            <title>Sitagliptin</title>
            <description>Sitagliptin is given before ingestion of meal</description>
          </group>
        </group_list>
        <measure>
          <title>Insulin Secretion After Ingestion of Meal</title>
          <description>Plasma insulin levels will be measured during 300 min after meal ingestion to estimation of insulin secretion</description>
          <population>Completer population</population>
          <units>mol/l/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.6" spread="2.8"/>
                    <measurement group_id="O2" value="24.7" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>All Study Participants</title>
          <description>Placebo first, then sitagliptin or sitagliptin first, then placebo</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Bo Ahrén</name_or_title>
      <organization>Lund University</organization>
      <phone>+46462220758</phone>
      <email>Bo.Ahren@med.lu.se</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

